| Identification | |
| Name: | amrinone |
| Synonyms: | - |
| CAS: | 60719-84-8 |
| EINECS: | 262-390-0 |
| Molecular Formula: | C10H9N3O |
| Molecular Weight: | 187.2 |
| InChI: | InChI=1/C10H9N3O/c11-9-5-8(6-13-10(9)14)7-1-3-12-4-2-7/h1-6H,11H2,(H,13,14) |
| Molecular Structure: |  |
| Properties | |
| Transport: | UN 2811 |
| Density: | 1.277 g/cm3 |
| Refractive index: | 1.625 |
| Appearance: | Crystalline Solid |
| Specification: |
? Amrinone , with CAS number of 60719-84-8, can be called (3,4'-Bipyridin)-6(1H)-one, 5-amino- ; [3,4'-bipyridin]-6(1H)-one, 5-amino- ; [3,4'-bipyridin]-6-ol, 5-amino- ; 5-Amino-3,4'-bipyridin-6(1H)-one ; 5-Amino-3,4'-bipyridin-6-ol ; 262-390-0 [EINECS/ELINCS] . Amrinone(CAS NO.60719-84-8) may increase myocardial ischemia. Blood pressure, pulseand EKG should be constantly monitored. Amrinone should only be diluted with normal saline or 1/2 normal saline; no dextrose solutions should be used. Furosemide should not be administered into an IV line delivering Amrinone.?It is used in the treatment of congestive heart failure and has been studied for use before coronary artery bypass surgery. |
| Packinggroup: | III |
| HS Code: | 29333999 |
| Usage: | A selective cAMP phosphodiesterase (PDE-3) inhibitor with positive inotropic and vasodilatory activity. Cardiotonic |
| Safety Data | |
| Hazard Symbols |
T:Toxic
|
 |
|
